Skip to main content
Grant Opportunities

NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01) – Feb 07, 2014

By April 24, 2013No Comments

…

Funding Opportunity Number: RFA-AR-14-008
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
CFDA Number: 93.846
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: Feb 07, 2014
Award Ceiling: $150,000
Expected Number of Awards:
Creation Date: Apr 23, 2013
Funding Opportunity Description: This Funding Opportunity Announcement (FOA) solicits applications for research awards designed to develop new and evaluate existing clinical trial outcome instruments/measures to better assess the benefits (efficacy and effectiveness) and adverse impacts of therapies employed to treat diseases and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and subsequent evaluation of both new and existing clinically relevant and patient-important outcome instruments/measures that could be further tested in existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, monitoring, treatment or cure of diseases and injuries of interest to the NIAMS. Outcome instruments/measures should be as generalizable as possible with the ultimate aim to impact patient care.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=231335

{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-14-008.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.